Xbrane Biopharma AB (XBRANE) — Financial Flexibility Index
Xbrane Biopharma AB (XBRANE) has a Financial Flexibility Index of 0.02x as of March 2026. Free cash flow of Skr2.42 Million (operating CF Skr-8.50 Million minus capex Skr10.93 Million) represents 0% of total liabilities (Skr120.60 Million). Check how strategically is Xbrane Biopharma AB's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Xbrane Biopharma AB Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Xbrane Biopharma AB across 13 annual periods. See XBRANE net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Xbrane Biopharma AB (2013–2025)
Year-by-year free cash flow to debt coverage for Xbrane Biopharma AB. For the full company profile including market capitalisation, see XBRANE company net worth.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.00x | Skr-111.05 Million | Skr-250.69 Million | Skr110.97 Million | ▼ -678.5% |
| 2024 | -0.13x | Skr-81.48 Million | Skr-133.73 Million | Skr633.89 Million | ▲ +84.1% |
| 2023 | -0.81x | Skr-389.91 Million | Skr-406.68 Million | Skr482.17 Million | ▼ -60.5% |
| 2022 | -0.50x | Skr-133.79 Million | Skr-193.92 Million | Skr265.63 Million | ▲ +9.1% |
| 2021 | -0.55x | Skr-142.26 Million | Skr-219.61 Million | Skr256.69 Million | ▲ +51.3% |
| 2020 | -1.14x | Skr-234.55 Million | Skr-238.41 Million | Skr206.06 Million | ▼ -19.4% |
| 2019 | -0.95x | Skr-147.40 Million | Skr-148.59 Million | Skr154.62 Million | ▼ -435.1% |
| 2018 | 0.28x | Skr48.30 Million | Skr46.71 Million | Skr169.81 Million | ▲ +119.2% |
| 2017 | -1.49x | Skr-33.50 Million | Skr-36.85 Million | Skr22.55 Million | ▲ +41.3% |
| 2016 | -2.53x | Skr-27.34 Million | Skr-39.43 Million | Skr10.81 Million | ▼ -526.0% |
| 2015 | -0.40x | Skr-11.24 Million | Skr-12.39 Million | Skr27.82 Million | ▲ +93.6% |
| 2014 | -6.35x | Skr-2.48 Million | Skr-2.67 Million | Skr390.70K | ▼ -46.1% |
| 2013 | -4.35x | Skr-2.20 Million | Skr-2.20 Million | Skr505.44K | — |